Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 84 (7) , 908-914
- https://doi.org/10.1038/labinvest.3700113
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitorsAIDS, 2002
- Tenofovir Diphosphate Is a Poor Substrate and a Weak Inhibitor of Rat DNA Polymerases α, δ, and ε*Antimicrobial Agents and Chemotherapy, 2002
- Metabolic acidosis in HIV-infected patients.Clinical Infectious Diseases, 2002
- Symptomatic Elevations of Lactic Acid and Their Response to Treatment Manipulation in Human Immunodeficiency Virus–Infected Persons: A Case SeriesClinical Infectious Diseases, 2001
- HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the NucleusJournal of Biological Chemistry, 2001
- Differential Incorporation and Removal of Antiviral Deoxynucleotides by Human DNA Polymerase γJournal of Biological Chemistry, 2001
- Letters to the EditorJournal of Hepatology, 2000
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving ZidovudineClinical Infectious Diseases, 1995